Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T cell lymphoma
- Registry ID
- EUCTR2017-000433-30
- Source registry
- EUCTR
- Status
- GB - no longer in EU/EEA
- Phase
- PHASE2
- Sponsor
- University College London
- Start date
- 2018-05-23
- Last update
- 2026-08-16
Conditions
- Cutaneous T cell lymphoma
Summary
Would the addition of radiotherapy to pembrolizumab improve the response to treatment and is it safe to give?
Locations
View on source registry